Organigram (TSE:OGI) Shares Down 5.9% – Should You Sell?

Organigram Holdings Inc. (TSE:OGI)’s stock price traded down 5.9% during trading on Tuesday. The stock traded as low as C$1.20 and last traded at C$1.28. Approximately 1,081,307 shares changed hands during mid-day trading, an increase of 463% from the average session volume of 192,157 shares. The stock had previously closed at C$1.36.

Organigram Stock Performance

The stock has a 50 day simple moving average of C$1.44 and a 200 day simple moving average of C$1.65. The company has a market cap of C$184.52 million, a price-to-earnings ratio of 2.13, a PEG ratio of 0.42 and a beta of 1.44. The company has a quick ratio of 2.62, a current ratio of 2.61 and a debt-to-equity ratio of 6.48.

Organigram (TSE:OGI) last issued its earnings results on Tuesday, August 11th. The company reported C$0.77 earnings per share for the quarter. Organigram had a return on equity of 21.99% and a net margin of 28.02%. The company had revenue of C$105.78 million during the quarter. As a group, analysts predict that Organigram Holdings Inc. will post 0.16 EPS for the current year.

Organigram Company Profile

Organigram Global Inc is listed on the NASDAQ Global Select Market and TSX. The Company’s wholly owned subsidiary, Organigram Inc, is a licensed cultivator and processor. Through its acquisition of Sanity Group GmbH (‘Sanity Group’), Organigram participates in the German medical cannabis market and other emerging markets within Europe. Organigram is focused on producing high-quality cannabis for adult consumers, as well as extending the Company’s global footprint. Organigram has also developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O’ Buds, SHRED, Monjour, Tremblant, Collective Project, Trailblazer, BOXHOT and DEBUNK.